Concepts (93)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
| Nicotine | 5 | 2021 | 213 | 2.16 | Why? |
| alpha7 Nicotinic Acetylcholine Receptor | 2 | 2021 | 92 | 1.66 | Why? |
| Electronic Nicotine Delivery Systems | 10 | 2018 | 561 | 1.63 | Why? |
| Toll-Like Receptor 7 | 2 | 2020 | 402 | 1.26 | Why? |
| Tobacco Products | 3 | 2018 | 245 | 1.25 | Why? |
| Receptors, Nicotinic | 1 | 2020 | 81 | 0.80 | Why? |
| Nitrosamines | 1 | 2018 | 4 | 0.76 | Why? |
| Smoking | 5 | 2021 | 3358 | 0.75 | Why? |
| Formaldehyde | 1 | 2017 | 135 | 0.66 | Why? |
| Tobacco | 1 | 2018 | 274 | 0.61 | Why? |
| Smokers | 4 | 2021 | 550 | 0.51 | Why? |
| Aerosols | 3 | 2018 | 5393 | 0.51 | Why? |
| Epitopes | 2 | 2021 | 4113 | 0.45 | Why? |
| Snake Venoms | 2 | 2021 | 29 | 0.44 | Why? |
| Adjuvants, Immunologic | 1 | 2020 | 1709 | 0.42 | Why? |
| Hot Temperature | 1 | 2018 | 1299 | 0.41 | Why? |
| Macrophages | 1 | 2021 | 2784 | 0.37 | Why? |
| Spike Glycoprotein, Coronavirus | 3 | 2021 | 37182 | 0.31 | Why? |
| Inpatients | 1 | 2021 | 5161 | 0.28 | Why? |
| Pulmonary Disease, Chronic Obstructive | 1 | 2020 | 3832 | 0.24 | Why? |
| Polymerase Chain Reaction | 1 | 2017 | 6740 | 0.24 | Why? |
| Non-Neuronal Cholinergic System | 1 | 2021 | 8 | 0.23 | Why? |
| Vaping | 2 | 2018 | 436 | 0.22 | Why? |
| Nicotinic Agonists | 1 | 2021 | 56 | 0.21 | Why? |
| Cholinergic Agents | 1 | 2020 | 26 | 0.21 | Why? |
| Neurotoxins | 1 | 2020 | 42 | 0.21 | Why? |
| Binding Sites, Antibody | 1 | 2021 | 466 | 0.20 | Why? |
| Sequence Homology | 1 | 2021 | 448 | 0.19 | Why? |
| Spectrometry, X-Ray Emission | 1 | 2018 | 21 | 0.19 | Why? |
| Amino Acid Sequence | 2 | 2021 | 6049 | 0.19 | Why? |
| Carcinogens | 1 | 2018 | 33 | 0.18 | Why? |
| Spectrophotometry, Ultraviolet | 1 | 2018 | 81 | 0.18 | Why? |
| Aldehydes | 1 | 2018 | 56 | 0.18 | Why? |
| Toxicity Tests | 1 | 2018 | 100 | 0.18 | Why? |
| Complex Mixtures | 1 | 2018 | 51 | 0.18 | Why? |
| Harm Reduction | 2 | 2018 | 392 | 0.17 | Why? |
| SARS Virus | 1 | 2021 | 13021 | 0.16 | Why? |
| Metals, Heavy | 1 | 2018 | 147 | 0.16 | Why? |
| Protein Structure, Tertiary | 1 | 2020 | 1565 | 0.15 | Why? |
| Protective Factors | 1 | 2021 | 1720 | 0.14 | Why? |
| Cloning, Molecular | 1 | 2017 | 1036 | 0.13 | Why? |
| Chromatography, High Pressure Liquid | 1 | 2018 | 669 | 0.13 | Why? |
| Sequence Alignment | 1 | 2020 | 2109 | 0.13 | Why? |
| Inhalation Exposure | 1 | 2018 | 405 | 0.13 | Why? |
| Immunity, Innate | 2 | 2020 | 6570 | 0.11 | Why? |
| Protein Conformation | 1 | 2021 | 4386 | 0.10 | Why? |
| Betacoronavirus | 4 | 2020 | 204454 | 0.09 | Why? |
| Pneumonia, Viral | 4 | 2020 | 243684 | 0.09 | Why? |
| Coronavirus Infections | 4 | 2020 | 253789 | 0.09 | Why? |
| Adaptive Immunity | 1 | 2020 | 2585 | 0.09 | Why? |
| Recombinant Proteins | 1 | 2017 | 3786 | 0.08 | Why? |
| Prevalence | 2 | 2021 | 25773 | 0.08 | Why? |
| Models, Molecular | 1 | 2021 | 7616 | 0.08 | Why? |
| Humans | 15 | 2021 | 930598 | 0.08 | Why? |
| Computational Biology | 1 | 2020 | 4514 | 0.07 | Why? |
| Molecular Docking Simulation | 1 | 2020 | 6902 | 0.07 | Why? |
| Signal Transduction | 1 | 2021 | 7207 | 0.07 | Why? |
| Antigens, Viral | 1 | 2021 | 6298 | 0.06 | Why? |
| Pandemics | 6 | 2021 | 389249 | 0.06 | Why? |
| European Union | 2 | 2017 | 565 | 0.06 | Why? |
| Olfaction Disorders | 1 | 2021 | 3704 | 0.06 | Why? |
| Antibodies, Monoclonal | 1 | 2021 | 8041 | 0.06 | Why? |
| Drug Repositioning | 1 | 2020 | 5683 | 0.06 | Why? |
| Limit of Detection | 2 | 2018 | 2698 | 0.05 | Why? |
| Flavoring Agents | 1 | 2018 | 20 | 0.05 | Why? |
| Antibodies, Viral | 2 | 2021 | 51949 | 0.04 | Why? |
| Cytokines | 1 | 2020 | 15010 | 0.04 | Why? |
| Comorbidity | 1 | 2021 | 34796 | 0.04 | Why? |
| Adult | 5 | 2021 | 244371 | 0.04 | Why? |
| Cross-Over Studies | 1 | 2018 | 867 | 0.04 | Why? |
| Single-Blind Method | 1 | 2018 | 1283 | 0.03 | Why? |
| China | 1 | 2021 | 50654 | 0.03 | Why? |
| United States | 1 | 2021 | 46150 | 0.03 | Why? |
| Severity of Illness Index | 1 | 2021 | 48226 | 0.03 | Why? |
| Male | 5 | 2021 | 367725 | 0.03 | Why? |
| Animals | 2 | 2021 | 78931 | 0.03 | Why? |
| Female | 5 | 2021 | 380317 | 0.03 | Why? |
| Smell | 1 | 2021 | 1851 | 0.03 | Why? |
| Risk Factors | 1 | 2021 | 71621 | 0.03 | Why? |
| Greece | 1 | 2018 | 2091 | 0.03 | Why? |
| Hospitalization | 1 | 2021 | 54280 | 0.02 | Why? |
| Immunologic Memory | 1 | 2021 | 3362 | 0.02 | Why? |
| Smoking Cessation | 1 | 2017 | 826 | 0.02 | Why? |
| Middle Aged | 3 | 2021 | 270681 | 0.02 | Why? |
| Self Report | 1 | 2017 | 3802 | 0.02 | Why? |
| Reproducibility of Results | 1 | 2018 | 11304 | 0.01 | Why? |
| Mutation | 1 | 2021 | 12376 | 0.01 | Why? |
| Europe | 1 | 2017 | 12702 | 0.01 | Why? |
| Surveys and Questionnaires | 2 | 2018 | 43792 | 0.01 | Why? |
| Cross-Sectional Studies | 2 | 2018 | 53120 | 0.01 | Why? |
| Vaccination | 1 | 2021 | 19050 | 0.01 | Why? |
| Adolescent | 1 | 2018 | 86841 | 0.01 | Why? |
| Young Adult | 1 | 2018 | 93724 | 0.01 | Why? |